Developing personalized nanomedicine drug delivery systems
Project Pace
About Us
Artificial Intelligence for NanoMedicine
Aim
Our goal is to create the platform for rapid development of personalized nanomedicine drug delivery systems. We intend to do it by developing the intellectual property of EVO-NANO results in accordance to market and regulatory demands.
Origin
We build upon the computational platform that is under development in H2020 FET-Open project EVO-NANO. The platform uses AI to generate and in silico test novel cancer treatments.
Objectives
IP Positioning
Macro Market Analysis
Application Analysis
Market Strategy
Exploitation
Igor Balaz
Biophysicist at University of Novi Sad
Marina Kovacevic
Computational chemist at University of Novi Sad
Lance Leverette
Professional market researcher and analyst